Immunome (IMNM) EBITDA Margin (2023 - 2025)
Immunome's (IMNM) quarterly EBITDA Margin came in at 1157.61% in Q2 2025, up 53482.0% YoY from N/an in Q2 2024, and up 24.12% on a QoQ basis from 1525.5% in Q1 2025.
Immunome (IMNM) EBITDA Margin (2023 - 2025) Analysis & Trends
Immunome (IMNM) has 3 years of EBITDA Margin data on file, last reported at 1157.61% in Q2 2025.
- Quarterly EBITDA Margin rose 53482.0% year-over-year to 1157.61% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 5947.9% (down 395359.0% YoY) and the FY2025 annual result came in at 3228.83%, up 15354.0% from the prior year.
- EBITDA Margin advanced to 1157.61% in Q2 2025, from 1525.5% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 129.96% in Q3 2023 to a low of 12857.05% in Q1 2024.
- A 3-year average of 2492.75% and a median of 1608.96% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2024 — EBITDA Margin plunged 1266792 bps — and 2025, when it surged 1133155 bps.
- Tracing IMNM's EBITDA Margin over 3 years: stood at 2473.94% in 2023, then decreased by 22 bps to 3030.31% in 2024, then soared by 62 bps to 1157.61% in 2025.
- The last three EBITDA Margin figures came in at 1157.61% (Q2 2025), 1525.5% (Q1 2025), and 3030.31% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,569,866.34% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,157.61% |
| Mar 31, 2025 | -1,525.50% |
| Dec 31, 2024 | -3,030.31% |
| Sep 30, 2024 | -1,736.15% |
| Jun 30, 2024 | -1,692.43% |
| Mar 31, 2024 | -12,857.05% |
| Dec 31, 2023 | -2,473.94% |
| Sep 30, 2023 | -129.96% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -189.13% |